ConductScience.org, home

Paper41909658

Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response.

Kerth HA and 15 others. Front Immunol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. Papers, record 41909658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41909658

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response.
PubMed
Journal
Front Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kerth HAHélène A
2Kächele MMartin
3Müller NNikolas
4Singh SSwati
5Tulessin MMargaret
6Sacherl JJulia
7Ates Öz EEdanur
8Su JJinpeng
9Bester RRomina
10Miko SSusanne
11Steiger KKatja
12Mogler CCarolin
13Busch DHDirk H
14Wettengel JMJochen M
15Protzer UUlrike
16Kosinska ADAnna D

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Vaccines, DNAMajor topic
Hepatitis B Surface AntigensMajor topic
Hepatitis B VaccinesMajor topic
Hepatitis B virusMajor topic
Hepatitis B, ChronicMajor topic
Animals
Mice
Immunization, Secondary
Female
CD8-Positive T-Lymphocytes
Vaccinia virus
Hepatitis B Antibodies
Humans
Antibody Formation
Vaccination

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115613305Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.J Virol2005https://conductscience.org/library/papers/15613305PubMed
234113610A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications.Front Cell Dev Biol2021https://conductscience.org/library/papers/34113610PubMed
311130078A Toll-like receptor recognizes bacterial DNA.Nature2000https://conductscience.org/library/papers/11130078PubMed
439937851Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/39937851PubMed
519500964Heterologous prime-boost vaccination.Curr Opin Immunol2009https://conductscience.org/library/papers/19500964PubMed
612200054Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire.Mol Immunol2002https://conductscience.org/library/papers/12200054PubMed
731346211Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection.Sci Rep2019https://conductscience.org/library/papers/31346211PubMed
831548710Restoring, releasing or replacing adaptive immunity in chronic hepatitis B.Nat Rev Gastroenterol Hepatol2019https://conductscience.org/library/papers/31548710PubMed
926776470Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.Vaccine2016https://conductscience.org/library/papers/26776470PubMed
1015100299Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.J Immunol2004https://conductscience.org/library/papers/15100299PubMed
1121602908High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice.PLoS One2011https://conductscience.org/library/papers/21602908PubMed
1218343847Occurrence, function and evolutionary origins of '2A-like' sequences in virus genomes.J Gen Virol2008https://conductscience.org/library/papers/18343847PubMed
1334284057Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.Antiviral Res2021https://conductscience.org/library/papers/34284057PubMed
1412938219Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen.Eur J Immunol2003https://conductscience.org/library/papers/12938219PubMed
1538012018Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models.Hum Vaccin Immunother2023https://conductscience.org/library/papers/38012018PubMed
1628453967Therapeutic vaccination for chronic hepatitis B.Curr Opin Virol2017https://conductscience.org/library/papers/28453967PubMed
1730326600The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data.Genes (Basel)2018https://conductscience.org/library/papers/30326600PubMed
1834452368Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications.Viruses2021https://conductscience.org/library/papers/34452368PubMed
1910846081Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.J Virol2000https://conductscience.org/library/papers/10846081PubMed
209989985T cell affinity maturation by selective expansion during infection.J Exp Med1999https://conductscience.org/library/papers/9989985PubMed

See all 52 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41909658

GET https://conductscience.org/api/papers/v1/41909658/references?page=2